Bristol-Myers Squibb Newsroom

William Blair Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating

Moomoo News00:32 ET

BofA Securities Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Cuts Target Price to $58

Moomoo NewsApr 17 19:31 ET

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and LENZ Therapeutics (LENZ)

TipRanksApr 16 04:23 ET

Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Maintains Target Price $36

Moomoo NewsApr 15 19:33 ET

BMO Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $61

Moomoo NewsApr 15 19:33 ET

Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $55

Moomoo NewsApr 15 19:33 ET

Wells Fargo Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $62

Moomoo NewsApr 15 06:31 ET

William Blair Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating

Moomoo NewsApr 15 06:31 ET

Hold Rating Maintained for Bristol-Myers Squibb Amid Camzyos Trial Setback

TipRanksApr 15 04:41 ET

Citi Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Cuts Target Price to $55

Moomoo NewsApr 11 19:33 ET

UBS Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Cuts Target Price to $54

Moomoo NewsApr 11 19:33 ET

Bristol-Myers Squibb Analyst Ratings

BenzingaApr 11 10:36 ET

UBS Cuts Price Target on Bristol-Myers Squibb to $54 From $60, Keeps Neutral Rating

MT NewswiresApr 11 08:24 ET

Raymond James Initiates Bristol-Myers Squibb(BMY.US) With Hold Rating

Moomoo NewsApr 10 18:31 ET

Bristol-Myers Squibb: Hold Rating Amid Mixed Revenue Projections and Market Challenges

TipRanksApr 10 16:32 ET

Morgan Stanley Maintains Bristol-Myers Squibb(BMY.US) With Sell Rating, Cuts Target Price to $36

Moomoo NewsApr 9 19:32 ET

Morgan Stanley Adjusts Price Target on Bristol-Myers Squibb to $36 From $37, Keeps Underweight Rating

MT NewswiresApr 9 09:33 ET

Bristol-Myers Squibb Analyst Ratings

BenzingaApr 8 12:04 ET

BMO Capital Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $61

Moomoo NewsApr 4 19:32 ET

Bernstein Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $62

Moomoo NewsApr 3 03:33 ET